TRT as 'modern natural': separating legitimate therapy from fitness culture spin

What did @lastrepshorts actually say?

Honestly? It's hard to tell. The transcript provided for this video is not a coherent rendering of what was said. What we have is a machine-generated transcription that appears to have failed completely, producing fragments about "hood kits" and "orchestra players" that bear no relationship to the video's stated topic: testosterone replacement therapy and the "modern natural" phenomenon in Turkish fitness culture.

The caption, written by the creator himself, is far more informative. Buğra Keskin frames TRT as potentially a "cover" for performance-enhancing drug use, asking whether it's a genuine medical necessity or a convenient label. The hashtags and caption suggest the video argues that many people presenting themselves as natural athletes are using TRT as social cover for what is effectively pharmacological enhancement.

Because the transcript is unusable, this fact-check will assess the claims implied by the caption and the known arguments in this debate, while flagging clearly where we're working from context rather than confirmed quotes.

Does the science back this up?

The core implied claim, that TRT is sometimes used as reputational cover rather than medical treatment, is well-supported. This is not fringe skepticism. It is a documented pattern.

Clinical hypogonadism is defined by both consistently low serum testosterone (generally below 300 ng/dL in US guidelines, with symptomatic confirmation) and accompanying symptoms including fatigue, low libido, and reduced muscle mass. Bhasin et al. (2018, New England Journal of Medicine) confirmed that TRT in genuinely hypogonadal men produces meaningful improvements in sexual function, bone density, and mood. That is the legitimate use case.

However, the global TRT market has expanded dramatically beyond that population. Rastrelli et al. (2019, Best Practice and Research Clinical Endocrinology and Metabolism) documented widespread testosterone prescribing to men with low-normal or even normal levels, particularly in direct-to-consumer telehealth contexts. In competitive fitness communities, the line between TRT dosing (typically 100-200 mg/week of testosterone) and low-dose performance enhancement is functionally invisible to observers, which is precisely the social dynamic the creator appears to be criticizing.

What did they get wrong (or right)?

Based on the caption framing, Keskin appears to be raising a legitimate skeptical point that deserves credit. The "modern natural" criticism is not new, but it is valid. Athletes using physician-prescribed testosterone at supraphysiological-leaning doses while competing in natural federations or presenting publicly as drug-free is a real and documented problem in recreational and competitive fitness.

Where the argument can go wrong, and where we cannot confirm Keskin's position without a readable transcript, is in the direction of overcorrection. Not everyone on TRT is gaming the system. A 45-year-old man with confirmed hypogonadism seeking treatment is not the same as a 28-year-old bodybuilder optimizing levels for aesthetics. Conflating the two does a disservice to patients with genuine hormonal deficiencies.

• Credit where it is due: calling out social dishonesty around drug use in fitness culture takes directness that most creators avoid.
• Risk: without clinical nuance, the message can stigmatize legitimate patients or discourage men with real symptoms from seeking evaluation.

What should you actually know?

If you are wondering whether your testosterone levels are a medical issue or a lifestyle optimization question, the answer starts with a blood test, not a TikTok video or a telehealth checkout page.

Genuine TRT requires documented low testosterone confirmed on two separate morning measurements, a clinical evaluation for underlying causes (pituitary issues, obesity, sleep apnea), and ongoing monitoring of hematocrit, PSA, and cardiovascular markers. Khera et al. (2016, Journal of Urology) found that cardiovascular risk assessment is particularly important before initiation, given ongoing debate about TRT's effects on cardiac outcomes in older men.

The social dynamic Keskin is describing is real. A 2020 survey published in the Journal of the International Society of Sports Nutrition found that testosterone was among the most commonly used performance-enhancing substances in recreational gym populations, well above clinical prevalence rates for hypogonadism would predict. Someone calling themselves "on TRT" in a fitness context may be on a physician-supervised protocol or may be using a prescription as social legitimacy. You cannot tell from the outside, and neither can they always tell you honestly.

What you can do: get your levels tested through a regulated provider, understand that symptoms matter as much as numbers, and be skeptical of any platform, clinic, or influencer that treats testosterone as a lifestyle upgrade rather than a hormone with serious downstream effects when misused.